Silence Therapeutics plcSLNEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Richard Ian Griffiths | 16.90% | 23.7M | ▼ -9.68pp | 2024-03-27 |
| Lombard Odier Asset Management | 5.70% | 8.0M | ▼ -4.70pp | 2024-11-14 |
| Invus Public Equities, L.P. | 5.30% | 7.4M | ▼ -0.70pp | 2024-11-12 |
| THE GOLDMAN SACHS GROUP, INC. | 2.20% | 2.3M | — | 2024-02-12 |
| Deep Track Capital, LP | 2.14% | 3.0M | ▼ -3.29pp | 2024-11-14 |